You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 CD14 genotype distribution in the Dutch Caucasian STD cohort.

From: The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology

      CD14 -260 C>T   
    1.1 (CC)   1.2 (CT)   2.2 (TT)  
   Total n % n % n %
  Total 217 66 30,4% 107 49,3% 44 20,3%
CT IgG+ LCx+ (CT DNA+) 135 38 28,1% 69 51,1% 28 20,7%
  MO+ 42 12 28,6% 24 57,1% 6 14,3%
  Symp 56 14 25,0% 31 55,4% 11 19,6%
  LAP+ 17 4 23,5% 10 58,8% 3 17,6%
  LCx- (CT DNA-) 82 28 34,1% 38 46,3% 16 19,5%
  MO+ 29 12 41,4% 11 37,9% 6 20,7%
  Symp 43 16 37,2% 14 32,6% 13 30,2%
  LAP+ 17 5 29,4% 8 47,1% 4 23,5%
  Total 359 96 26,7% 185 51,5% 78 21,7%
CT IgG- LCx+ (CT DNA+) 49 15 30,6% 23 46,9% 11 22,4%
  MO+ 16 3 18,8% 10 62,5% 3 18,8%
  Symp 19 5 26,3% 11 57,9% 3 15,8%
  LAP+ 10 3 30,0% 6 60,0% 1 10,0%
  LCx- (CT DNA-) 310 81 26,1% 162 52,3% 67 21,6%
  MO+ 88 20 22,7% 53 60,2% 15 17,0%
  Symp 103 26 25,2% 51 49,5% 26 25,2%
  LAP+ 37 6 16,2% 20 54,1% 11 29,7%
Healthy Controls   170 48 28,2% 82 48,2% 40 23,5%
  1. C. trachomatis IgG positive and negative patients, divided in CT DNA (LCx) positive and negative and subdivided in coinfection with other microorganisms (N. gonorrhoea, T. vaginalis, C. albicans, H. simplex virus 1 & 2), symptoms (vulvovaginal discharge, abdominal pain, dysuria, bleeding during/after coitus) and lower abdominal pain. Abbreviations: CT: C. trachomatis; MO+: microorganism positive; LAP+: lower abdominal pain positive; Symp: symptoms positive